Latest News

Date Title Topic
30 Sep 2015 ESMO Video Commentary: Nivolumab Benefit Continues in NSCLC Lung and other thoracic tumours - Immuno-oncology
29 Sep 2015 ESMO Commentary: New Promising Options are Available for Renal Cell Carcinoma Genitourinary cancers - Immuno-oncology - Anticancer agents & Biologic therapy
29 Sep 2015 ESMO Commentary: TOPGEAR results set to unify global treatment of gastric cancer Gastrointestinal cancers
29 Sep 2015 ESMO Commentary: Specialised staff required for the nutrition and family teams in supportive care Palliative and supportive care
28 Sep 2015 ESMO Commentary: Innovative approaches and drugs in early development phase show promising results in solid tumours Anticancer agents & Biologic therapy
28 Sep 2015 ESMO @ ECC 2015: Comprehensive Genomic Profiling Detects High Frequency of ERBB2 Extracellular Domain Mutations in Multiple Cancer Types Personalised medicine - Translational research
28 Sep 2015 ESMO Commentary: A new promise for a rare skin cancer Immuno-oncology
28 Sep 2015 ESMO Commentary: Preserving fertility in breast cancer patients: new promises Breast cancer
28 Sep 2015 ESMO Commentary: Genomic landscape in lung cancer: steps forward in rapidly identifying genomic alterations Melanoma - Lung and other thoracic tumours
28 Sep 2015 ESMO @ ECC 2015: Comprehensive Genomic Profiling of BRAF in a Large Series of Lung Cancer Samples Translational research - Lung and other thoracic tumours
28 Sep 2015 ESMO @ ECC 2015: Response to EGFR Agents in Combination With Chemotherapy Demonstrated in Patients with Metastatic Colorectal Cancer of Rare KRAS Molecular Subtype Gastrointestinal cancers - Anticancer agents & Biologic therapy
28 Sep 2015 ESMO Commentary: Preliminary Results from PERUSE Study Increase Treatment Options in HER-Positive Patients with Metastatic Breast Cancer Breast cancer
27 Sep 2015 ESMO Commentary: Immune therapy brings new treatment options for lower GI cancers Gastrointestinal cancers - Immuno-oncology
27 Sep 2015 ESMO Commentary: The variable access to best cancer care in Europe may affect clinical outcomes and survival in older patients Bioethics, legal and economic issues
27 Sep 2015 ESMO @ ECC 2015: Progression-Free Survival Prolonged with Everolimus in Patients with Advanced Lung/Gastrointestinal Neuroendocrine Tumours Endocrine cancers - Anticancer agents & Biologic therapy